US 9050263
Pharmaceutical compositions for the treatment of Helicobacter pylori
granted A61KA61K31/395A61K31/43
Quick answer
US patent 9050263 (Pharmaceutical compositions for the treatment of Helicobacter pylori) held by RedHill Biopharma Ltd. expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RedHill Biopharma Ltd.
- Grant date
- Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/395, A61K31/43, A61K31/435, A61K31/438